Chembio Diagnostics Inc CEMI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EST
5.86quote price arrow up+0.08 (+1.30%)
Volume
17,910
Close
5.78quote price arrow up+0.55 (+10.40%)
Volume
741,639
52 week range
2.25 - 15.89

...

Loading . . .

KEY STATS

  • Open5.24
  • Day High5.86
  • Day Low5.24
  • Prev Close5.24
  • 52 Week High15.89
  • 52 Week High Date04/23/20
  • 52 Week Low2.25
  • 52 Week Low Date03/16/20
  • Market Cap116.74M
  • Shares Out20.18M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta1.90
  • 1 Year % Change42.14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-4.78
  • Fwd P/E (NTM)-6.21
  • EBITDA (MRQ)-16.099M
  • ROE (MRQ)-74.57%
  • Revenue (MRQ)29.09M
  • Gross Margin (MRQ)25.09%
  • Net Margin (MRQ)-76.55%
  • Debt To Equity (MRQ)53.92%

EVENTS

  • Earnings Date03/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Chembio Diagnostics Inc News

There is no recent news for this security.

Latest CEMI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Chembio Diagnostics, Inc. is a provider of point-of-care diagnostic products for the detection and diagnosis of infectious diseases. The Company is primarily focused on expanding its product portfolio based upon its Dual Path Platform (DPP). The Company's products include rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The Company’s point-of-care infectious disease...
Gail Page
Chairman
Richard Eberly
President
Neil Goldman
Chief Financial Officer
Javan Esfandiari
Executive Vice President
Chuck Caso
Vice President
Address
555 Wireless Blvd
Hauppauge, NY
11788-3966
United States